Functioning of Elder Muscle; Understanding Recovery
FEMUR
Muscle Phenotyping in Frail Older Patients Having Hip Surgery Following Fracture
1 other identifier
observational
80
1 country
1
Brief Summary
As people get older, the amount of skeletal muscle in the body can decrease. When the amount of this muscle in the body gets very low, there is an increased risk of falling, and not only is recovery to any injury slower, but more complications can be experienced following surgery, and patients may end up being more dependent on the help of others for meeting daily activities. However, it is not clear whether it is simply the amount of muscle that is in the body that is important for health, or whether it is the ability of muscle to function properly which is important. This research study is looking at the way muscles of frail older people function; not just how strong they are, but the amount of fats and protein that there are in muscle cells, and how the genes in the muscles are being expressed (genes being a collection of chemical information that carry the instructions for making the proteins a cell will need to function). We will also investigate whether recovery from hip fracture is impacted by the amount of muscle that there is in the body, and/or the functioning of this muscle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2021
CompletedFirst Submitted
Initial submission to the registry
February 8, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 1, 2026
August 1, 2025
4 years
February 8, 2021
March 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Skeletal Muscle messenger ribonucleic acid (mRNA) expression (injured leg)
mRNA expression of 384 gene targets spanning a number of cellular functions, in a vastus lateralis muscle biopsy taken from the injured leg
On recruitment
Secondary Outcomes (23)
Skeletal Muscle mRNA expression (un-injured leg)
On recruitment
Intramyocellular lipid density (injured leg)
On recruitment
Intramyocellular lipid density (uninjured leg)
On recruitment
Body weight
on recruitment
Grip Strength
up to 3 days post surgery
- +18 more secondary outcomes
Eligibility Criteria
Individuals \>65 years who have been admitted to Queens Medical Centre, Nottingham, UK for surgical repair of a hip fracture sustained following a low impact fall.
You may qualify if:
- Clinical Frailty Score (assessed as part of standard care) ≥ 4
- Fractured hip, sustained following a fall, that requires surgery
- Good understanding of spoken and written English language
- Able to give informed consent, or availability of a legally acceptable surrogate to provide consent
You may not qualify if:
- Those who fell and sustained their hip fracture greater than 12 hours prior to hospitalisation.
- Those who have fallen and sustained a hip fracture whilst an in-patient in hospital
- Those who sustained the hip fracture as a result of high impact trauma (e.g. road traffic accident)
- Surgery carried out later than 96 hrs after fall
- Chronic neurological, inflammatory or musculoskeletal disorders which result in muscle wasting, e.g. Multiple sclerosis, muscular dystrophy, rheumatoid arthritis
- Any co-morbidity which precludes hip surgery
- Those with a compromised swallowing reflex which would prevent the participant from taking fluids orally, will be excluded.
- Those taking diabetes medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nottinghamlead
- Nottingham Biomedical Research Centrecollaborator
Study Sites (1)
Queens Medical Centre; Department of Orthopaedics
Nottingham, NG72UH, United Kingdom
Biospecimen
Skeletal Muscle biopsy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ben Ollivere, MBBS
University of Nottingham
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2021
First Posted
February 21, 2021
Study Start
January 4, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
April 1, 2026
Record last verified: 2025-08